جست‌وجوی استاد و پژوهشگر

• T Cell Immunology
• Drug Allergy
• Vaccine Development
• +۷ مورد دیگر

Clinical Professor Michaela Lucas is a distinguished Clinical Immunologist/Allergist and Immunopathologist at The University of Western Australia Medical School with conjoint appointments at Sir Charles Gairdner Hospital, Pathwest Laboratory Medicine, and the Perth Children's Hospital. She leads the Immunology and Transplantation Lab, directing a multi-disciplinary team of clinical and basic science researchers, microsurgeons, and technicians focused on immunological research with direct clinical applications. Doctor of Medicine (Dr Med MD), University of Duisburg-Essen (1998) Medical Degree, University of Duisburg-Essen (1995) Professor Lucas's research spans T cell immunology with specific expertise in T cell mediated drug allergies, anti-viral T cell responses, vaccine development, and the role of inflammation in adaptive immunity during organ transplantation. Her innovative work now includes leading the PERTH Trial (Plastic Exposure Reduction Transforms Health), a world-first study investigating plastics exposure impacts on human health. Her research integrates clinical practice with laboratory investigation to address critical gaps in understanding immune responses. Analysis of her recent publications reveals a strong focus on antibiotic allergy management, with multiple randomized controlled trials examining educational interventions for non-specialists and the impact of allergy labels on antimicrobial stewardship. Her work on the BRACE Trial demonstrates significant contributions to understanding SARS-CoV-2 immunity and vaccine responses, while her regional leadership is evident in Asia-Pacific collaborative studies on chronic rhinosinusitis and allergic rhinitis management. WA Women's Hall of Fame (2025) Brightest Minds Alumni Award (2024) Early Career Researcher Award (2024) Developed ASCIA Food Allergy Dietitian Recognition Program Devil facial tumour disease vaccine development contributions Past President of ASCIA (Australasian Society of Clinical Immunology and Allergy) Professor Lucas serves as Principal or Co-Investigator on 12 major research grants totaling millions in funding, with active projects extending through 2028. Her leadership extends to directing two investigator-driven randomized controlled trials in antibiotic allergy and serving as co-Director of the National Allergy Council. She mentors numerous students and researchers while maintaining active clinical practice in immunology and allergy at multiple major hospitals across Western Australia. At the Immunology and Transplantation Lab, Professor Lucas oversees research programs investigating tissue-resident immunity after organ transplantation, drug allergy mechanisms, and the systemic impacts of environmental exposures. Her team collaborates extensively with national and international partners, with recent work focusing on the intersection of environmental health and immunology through the groundbreaking PERTH Trial.

• Biostatistics
• Clinical Trials
• Survival Analysis
• +۳ مورد دیگر

Dr. Lee S. McDaniel is an Assistant Professor (tenured) in the Department of Biostatistics & Data Science at LSU Health Sciences Center New Orleans. He holds a PhD from the University of Wisconsin-Madison (2014), an MS in Computer Science from the College of William and Mary (2008), and a BS in Mathematics from Rose-Hulman Institute of Technology (2006), with a supporting emphasis in Economics. His research focuses on biostatistical methodologies applied to clinical trials, survival analysis, and medical data visualization. Key areas include neuroinflammation in HIV/AIDS research, surgical outcomes in head and neck cancer, and predictive modeling for respiratory conditions like laryngotracheal stenosis. His work frequently bridges statistical rigor with clinical applications in oncology, otolaryngology, and immunology. Teaching responsibilities include advanced courses such as Survival Analysis, Design and Analysis of Experiments, and Data Visualization, reflecting his expertise in statistical methodologies. He has contributed to peer-reviewed journals like AIDS , Head and Neck , and Statistics in Biopharmaceutical Research . Dr. McDaniel actively serves on multiple university committees, including the Bachelor of Science in Public Health steering committee and the School of Public Health CEPH self-study group. He also reviews for high-impact journals such as Statistical Modelling and Statistics in Medicine .

• Cybersecurity
• Network Security
• Healthcare Information Security
• +۳ مورد دیگر

Young B. Choi is a Professor in the Department of Engineering & Computer Science at Regent University, specializing in cybersecurity, network security, and healthcare information security. He has held academic positions at institutions including James Madison University and the University of Missouri-Kansas City, and industry roles at companies like Creative Technology Ltd. and Compaq Computer Corporation. His research focuses on securing telecommunications, healthcare data privacy (HIPAA compliance), and emerging technologies like blockchain. Dr. Choi has served as an associate technical editor of the IEEE Communications Magazine since 2005 and contributed to over 150 refereed publications. He is an Outstanding Contributor in the TeleManagement Forum’s University Community Program and a member of the LoRa Alliance. Education: Ph.D. & M.S. in Computer Networking from University of Missouri-Kansas City; M.S. in Computer Science from KAIST; B.S. in Computer Science & Statistics from Chonnam National University. His research interests span secure service management, information assurance for homeland security, and cybersecurity in telemedicine. Key contributions include frameworks for HIPAA compliance audits, mitigation strategies for 5G security risks, and blockchain applications in patient data protection. Dr. Choi has authored Selected Readings in Cybersecurity (Cambridge Scholars Publishing, 2018) and contributed to multiple technical specifications and book chapters. Notable awards include the 2016 Regent University Faculty Excellence Award and a 1996 Best Paper Award at IEEE NOMS. His work frequently addresses real-world cybersecurity challenges, such as analyzing high-profile data breaches (e.g., Facebook, Equifax) and advancing BYOD security through NAC and next-gen firewalls.

• Interventional Cardiology
• Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention
• Complex Hemodynamic Procedures (CHIP)
• +۵ مورد دیگر

Raja Hatem is a Clinical Associate Professor at the Université de Montréal’s Faculty of Medicine, Department of Medicine. He is a renowned interventional cardiologist specializing in complex coronary interventions, particularly chronic total occlusion (CTO) percutaneous coronary intervention (PCI) and complex hemodynamic procedures (CHIP). He serves as the Cath Lab Director and Director of the CTO-CHIP Program at Hôpital du Sacré-Cœur de Montréal, part of the CIUSSS Nord-de-l’Île-de-Montréal. Dr. Hatem completed his medical degree at Université de Montréal (2009), followed by residencies in Internal Medicine and Cardiology (2015). He further specialized in interventional cardiology at Columbia University Medical Center (2017). His expertise includes innovative techniques in vascular interventions and the use of advanced medical devices, such as the first operator in Canada to deploy critical tools like the SyncVision iFR system (2018), Mamba microcatheter (2020), and MicroRx microcatheter (2024). His research focuses on optimizing CTO-PCI outcomes, radiation exposure reduction, and procedural safety. He has authored and co-authored over 30 peer-reviewed articles, chapters in interventional cardiology manuals, and contributed to global guidelines such as the Global Chronic Total Occlusion Crossing Algorithm (2021). His awards include the Bayer Fellowship (2015–2016) and multiple honors for clinical excellence and innovation. Dr. Hatem is a sought-after international lecturer and has pioneered techniques like the “zero-contrast CTO-PCI” and the “self-made covered stent technique.” He actively participates in clinical trials and registries, including the OPEN-CTO registry, which evaluates retrograde CTO-PCI outcomes. His work bridges clinical practice, research, and medical education, emphasizing patient-centered innovation.

Maria Giulia Lionettoمشاهده پروفایل

دانشیار

• Physiology
• Environmental Physiology
• Animal Physiology
• +۵ مورد دیگر

Maria Giulia Lionetto is an Associate Professor of Physiology (BIO/09) at the Department of Biological and Environmental Sciences and Technologies, University of Salento. She has been serving in this position since 2015, following her appointment as Researcher in Physiology from 2000-2015. Her research is conducted at the Ecotekne Center in Lecce, Italy. Her primary research interests include Environmental Physiology, Animal Physiology, Physiology of epithelia, and Cellular Physiology. Dr. Lionetto's work focuses on ion transport mechanisms, cell volume regulation, cellular responses to environmental stressors, biomarker development, and antioxidant properties of plant compounds. Her research has significant applications in environmental monitoring and pollution assessment. Dr. Lionetto has published extensively in high-impact journals, with recent work concentrating on carbonic anhydrase as a biomarker, oxidative potential of particulate matter, cellular responses to environmental pollutants, and antioxidant compounds. Her publications demonstrate a strong interdisciplinary approach connecting physiology, environmental science, and toxicology. Among her honors, she is a member of the Italian Society of Physiology and the Society of Environmental Toxicology and Chemistry. She serves as Associate Editor for Frontiers in Physiology and Topic Editor for International Journal of Molecular Sciences. She has also guest-edited multiple special issues on carbonic anhydrase research and environmental biomarkers. Dr. Lionetto earned her PhD in Fundamental Ecology in 1996 and her Degree in Biological Sciences from the University of Lecce in 1992 with highest honors. She has received recognition including the 'Giovani promesse della cultura pugliese' cultural award named after Nico Monfredi in 1993.

• Patient-Reported Outcomes (PROs)
• Clinical Trials
• Healthcare Research
• +۵ مورد دیگر

Dr. Rebecca Mercieca-Bebber is an NHMRC Early Career Fellow at the NHMRC Clinical Trials Centre, University of Sydney, and associated with Sydney Medical School. She holds a PhD in methodological issues related to patient-reported outcomes (PROs) in clinical trials and focuses on optimizing their design, implementation, and reporting. Her work addresses challenges like missing data and patient preferences, with contributions to international guidelines such as the SPIRIT-PRO extension. She has led over 20 clinical trials and was past chair of the ISOQOL Australia and New Zealand Special Interest Group. Education: Completed her PhD supported by the Sydney Catalyst full scholarship (2014–2017). She also holds coursework awards and has been involved in developing educational initiatives for PRO integration in clinical research. Research interests include PRO methodology, missing data strategies, patient preferences, and ethical considerations in PRO use. She advocates for equity in PRO assessment for culturally diverse and Indigenous populations. Recent work explores survivorship care plans, PRO reporting standards, and ethical frameworks for patient involvement. Scientific awards include the NHMRC Early Career Fellowship (2018), Cancer Research Network 10th Anniversary Award (2016), and multiple travel grants and scholarships. She has secured grants for projects like HyNOVA and the development of PRO ethics guidelines. Her advising contributions include mentoring future PhD students on PRO-related topics like cancer survivorship and PRO implementation. Grants highlight her focus on PRO integration in diverse healthcare settings and improving trial design through education. Labs/Teams: Active in the NHMRC Clinical Trials Centre, ISOQOL, and the PROMIS International Collaboration. Collaborates with multidisciplinary teams on PRO-related studies and guideline development.

Ferdinand Schweserمشاهده پروفایل

دانشیار

• Quantitative MRI
• Brain Iron Metabolism
• Multiple Sclerosis
• +۳ مورد دیگر

Ferdinand Schweser is an Associate Professor at the Jacobs School of Medicine and Biomedical Sciences , University at Buffalo, with joint appointments in Biomedical Engineering and Radiology. As Technical Director of the Center for Biomedical Imaging, his work focuses on quantitative MRI techniques , brain iron abnormalities in multiple sclerosis (MS) , and neurodegenerative disorders . His research includes paramagnetic rim lesions , quantitative susceptibility mapping (QSM) , and neuroinflammation in MS. Academic Rank: Associate Professor University: University at Buffalo School: Jacobs School of Medicine and Biomedical Sciences Department: Neurology Dr. Schweser’s research bridges advanced MRI methodologies with clinical applications in MS, emphasizing iron metabolism , gray and white matter pathology , and longitudinal disease progression . Current projects involve IRONMAP for tracking brain iron abnormalities and QSM algorithm validation . His work highlights paramagnetic rim lesions as predictors of relapse and disability in MS, alongside studies on thalamic atrophy and cognitive recovery . Articles also explore diffusion tensor imaging (DTI) , in vivo spinal cord imaging , and microglial activation in animal models. Key themes include neuroinflammation , iron dyshomeostasis , and biomarker development for neurodegenerative diseases. Contact: schweser@buffalo.edu | Office: 6045 Clinical and Translational Research Center, Buffalo NY

Gregory A. Abelمشاهده پروفایل

استاد

• Hematologic Malignancies
• Health Services Research
• Outcomes Research
• +۷ مورد دیگر

Gregory A. Abel, MD, MPH, is a Professor of Medicine at Harvard Medical School and a Senior Physician at Dana-Farber Cancer Institute (DFCI), where he is a member of the Divisions of Hematologic Malignancies and Population Sciences. He directs the Older Adult Hematologic Malignancy (OHM) Program and the Clinical Ethics Service at DFCI, and co-chairs the Ethics Advisory Committee. His clinical and research work bridges oncology, geriatrics, bioethics, and health services research. MD and MPH, Columbia University (2000) Residency in Internal Medicine, Massachusetts General Hospital Fellowship in Hematology/Oncology, Dana-Farber/Partners CancerCare Dr. Abel’s research focuses on improving outcomes for patients with hematologic malignancies, especially older adults. His work emphasizes health services research, patient-reported outcomes, geriatric assessment, and ethical issues in cancer care. He investigates disparities in clinical trial access, the impact of frailty, and the integration of digital health tools. His recent studies explore AI ethics, climate-conscious medicine, and equity in eligibility criteria. He leads a research lab applying population-level data to enhance patient-centered care across the cancer trajectory. His recent publications reflect a strong trend toward equity, ethics, and innovation in oncology. Key themes include racial disparities in trial access, digital health for functional monitoring, ethical deployment of AI, and sustainability in cancer care. He frequently publishes in top-tier journals such as JAMA Oncology, Blood, The Lancet Haematology, and The New England Journal of Medicine. Co-Chair, DFCI Ethics Advisory Committee Director, Clinical Ethics Service, DFCI Director, Older Adult Hematologic Malignancy Program Senior Physician, Dana-Farber Cancer Institute Dr. Abel is deeply involved in mentoring, grant-funded research, and national guideline development, including contributions to American Society of Hematology guidelines. His work is supported by institutional and federal funding, though specific grants are not listed. He collaborates across disciplines, including oncology, geriatrics, bioethics, and public health, to address complex challenges in blood cancer care. He is affiliated with multiple research centers, including the Adult Leukemia Program and the Population Sciences Division at DFCI. His lab focuses on real-world data, patient-reported outcomes, and intervention development to improve care delivery and equity.

Shashkova Tatyana Leonidovnaمشاهده پروفایل

دانشیار

• Environmental Science
• Toxicology
• Aquatic Ecology
• +۳ مورد دیگر

Shashkova Tatyana Leonidovna is an Associate Professor at the Department of Ecology and Nature Management, School of Ecology and Geography, Siberian Federal University. She holds a Candidate of Biological Sciences degree and specializes in biotesting and environmental monitoring of aquatic environments. Her work focuses on developing standardized methods using Daphnia magna and Artemia salina to assess water, soil, and waste toxicity. Education: Master's in Biology, Krasnoyarsk State University (2005) Advanced Training: Multiple certifications in e-learning, English for non-linguists, and student management at SFU (2016-2019). Research Interests: Her scientific contributions center on operational biotesting technologies , heavy metal pollution analysis, and environmental safety. She has developed patented methods for exposing test organisms and improving reproducibility in toxicity experiments. Her studies examine how medium composition, temperature, and exposure time affect bioassay outcomes. Publications Trends: Over 15 years, her work spans heavy metal toxicity , cladoceran bioassays , saline water assessment , and environmental diagnostics . Key subfields include toxicant exposure dynamics , bioindicator sensitivity , and standardized environmental protocols . Scientific Awards: She is a member of the Siberian branch of SETAC Russian Language Branch, contributing to ecotoxicology standards and environmental protection. Teaching: She instructs courses on Ecology , Sustainable Development , Environmental Monitoring , and Plant Taxonomy . She also leads educational practices in botany and advanced biotesting methodologies.

Bernardo Maria Esterمشاهده پروفایل

دانشیار

• Gene Therapy
• Hematopoietic Stem Cell Transplantation
• Pediatric Immunohematology
• +۵ مورد دیگر

Bernardo Maria Ester serves as Associate Professor of Pediatrics at Vita-Salute San Raffaele University's School of Medicine, where he holds multiple leadership roles including Member of the Steering Committee for the PhD Program in Molecular Medicine and Deputy Director of its 'Cell and Gene Therapy' curriculum. His clinical work centers at IRCCS San Raffaele Hospital as Head of the Pediatric Immuno-hematology Unit and Coordinator of the Pediatric Allogeneic Transplant Area. PhD in Biological Characterization and Clinical Application of Human Mesenchymal Stem Cells (Leiden University, 2010) Specialization in Pediatrics (University of Pavia, 2005, cum laude ) Degree in Medicine and Surgery (University of Pavia, 2000, cum laude ) His research bridges clinical practice and laboratory investigation with focus on gene therapy for metabolic disorders and hematopoietic stem cell transplantation . As a translational physician-scientist, he pioneered the first-in-human lentiviral gene therapy trial for Mucopolysaccharidosis Type I (Hurler variant) serving as Principal Investigator. His work spans stem cell biology, immunomodulation using mesenchymal stromal cells, and therapeutic development for rare pediatric diseases including ADA-SCID and Metachromatic Leukodystrophy. Analysis of his 15 most recent publications reveals consistent focus on ex-vivo gene therapy (72% of works), with particular emphasis on mucopolysaccharidoses and lysosomal storage disorders. His clinical research examines long-term outcomes, skeletal manifestations, and real-world implementation challenges, while basic science contributions explore transgene optimization and immunomodulatory mechanisms. AIRC Investigator Grant (2009) for tumor angiogenesis research Ministry of Health Young Researcher Grant (2008) Telethon Foundation Core Grant as Principal Investigator (2016-2021) European Commission Framework Program participation (Allostem, RETHRIM) As an educator, he supervises PhD candidates across multiple institutions and mentors 4 pediatric residents annually. His clinical trials portfolio includes national and international studies on gene therapy for ADA-SCID, Wiskott-Aldrich syndrome, and beta-thalassemia. At SR-TIGET (San Raffaele Telethon Institute for Gene Therapy), he leads the Pediatric Clinical Research Unit and serves as Project Leader developing novel cellular therapies.

• Connected Health
• Sport Science
• Wearable Technology
• +۶ مورد دیگر

Brian Caulfield is a Professor and Lead Investigator at the ARCH (Applied Research for Connected Health) Centre at University College Dublin, where he directs industry-focused research on technology-enhanced human performance in connected health and sport. He leads the Sensing and Actuation research group and has co-authored 180+ publications and 6 patents. His research integrates: Wearable technology for real-world mobility assessment and gait analysis Machine learning applications in sports injury prevention and rehabilitation Digital biomarker validation for chronic conditions (COPD, Parkinson's, MS) Athlete health frameworks and pain assessment toolkits Recent articles (2024-2025) demonstrate strong focus on: Clinical translation of digital mobility metrics Wearable device validation across diverse populations AI-driven training optimization for athletes Global health applications in resource-limited settings He has supervised over 20 graduate students (MSc/PhD) and contributes to major consortia like Mobilise-D and INTERLIVE-Network, developing standards for wearable data in clinical trials.

SAITO Shoichiمشاهده پروفایل

استاد

• Information Security
• Computer Systems
• Software Engineering
• +۳ مورد دیگر

Professor Shoichi Saito is a distinguished academic at Nagoya Institute of Technology, where he serves in the Department of Information Engineering within the College of Engineering. His research focuses on information security, computer systems, and software engineering, with particular expertise in IoT security, distributed systems, and network security. Professor Saito earned his Doctor of Engineering from Ritsumeikan University in March 2000. Prior to his current position, he served as Assistant Professor, Lecturer, and Associate Professor at Wakayama University's Faculty of Systems Engineering from 1998 to 2006. His research interests span multiple critical areas of modern computing: Information security with focus on IoT device protection Distributed systems and blockchain technologies Mobile application security, particularly for Android platforms Confidential information protection using virtual machine technologies Network security and anonymous communication systems Professor Saito's research outputs demonstrate a consistent focus on practical security solutions for emerging technologies. His recent work has centered on IoT security, data usage control in distributed environments, and advanced taint tracking mechanisms for mobile applications. His research bridges theoretical security concepts with practical implementation challenges. Among his notable recognitions are multiple awards from the Information Processing Society of Japan's Computer Security Research Group, including CSS2024 Student Paper Awards and Encouragement Awards. Professor Saito actively contributes to the academic community through committee memberships, including the Nagoya City Personal Information Protection Council and various program committees for the Information Processing Society of Japan. He has secured significant research funding, most recently for projects on IoT device emulation and virtual execution platform remote authentication.

Sophie Merrild Juulمشاهده پروفایل

استادیار

• Clinical Research Methodology
• Evidence-based Medicine
• Randomized Clinical Trials
• +۷ مورد دیگر

Sophie Merrild Juul is a Tenure Track Assistant Professor in the Department of Psychology at the University of Copenhagen's Faculty of Social Sciences. Her research focuses on clinical research methodology within adult psychiatry and clinical psychology, with particular expertise in randomized clinical trials, systematic reviews, and meta-analyses. Education: PhD fellow, University of Copenhagen (2018-present) M.Sc. in Psychology, University of Copenhagen (2011-2016) Dr. Juul's research interests center on evidence-based medicine and clinical research methodology, with specific focus on psychotherapy research, particularly mentalization-based therapy (MBT) for personality disorders. She investigates methodological approaches to improve psychiatric research, including outcome measurement and trial design. Her work bridges clinical practice with rigorous scientific methodology to advance evidence-based approaches in mental healthcare. Her recent publications demonstrate a strong focus on systematic reviews and meta-analyses across various psychiatric conditions including personality disorders, PTSD, depression, and ADHD. She is particularly interested in methodological issues related to psychiatric research, advocating for more appropriate outcome measures that align with those used in other medical specialties. Research Grants: Research grant from Trygfonden (2018, 2.585.799 DKK) Research grant from the Research Fund, Capital Region of Denmark (2017, 1.596.000 DKK) Dr. Juul collaborates extensively with researchers across multiple institutions on systematic reviews and clinical guidelines. Her current projects include developing transdiagnostic core outcome sets for mental health disorders and investigating novel treatment approaches for complex psychiatric presentations.

Ananth V Annapragadaمشاهده پروفایل

استاد

• Translational imaging
• Nanoparticle contrast agents
• Molecular imaging
• +۶ مورد دیگر

Ananth V Annapragada, PhD , is a Professor of Radiology and Obstetrics & Gynecology at Baylor College of Medicine in Houston, Texas, where he also serves as Vice Chief for Research & Director of Basic Research in Radiology at Texas Children’s Hospital . He is a member of the Dan L Duncan Comprehensive Cancer Center and leads the Translational Imaging Group (TIGr) , an interdisciplinary team developing next-generation imaging technologies. Education & Training While the text does not list specific degrees, Dr. Annapragada’s extensive patent record (≈37 granted patents) and >90 peer-reviewed publications indicate advanced training in biomedical engineering and imaging sciences. Research Interests His work bridges engineering, biology, and clinical medicine: Nanoparticle Contrast Agents: liposomal and polymeric agents for CT/MRI. Molecular Imaging: targeted probes for Alzheimer’s plaques, tumor macrophages, and atherosclerotic lesions. Device Development: low-field permanent-magnet MRI systems and NIR-II fluorescence imaging platforms. Clinical Translation: 3-D printed surgical models, AI-enhanced COVID-19 diagnostics, and patient-specific stroke prediction. Scientific Awards Fellow, American Institute of Medical and Biological Engineers Fellow, National Academy of Inventors (December 2020) Laboratories & Teams The Translational Imaging Group (TIGr) comprises engineers, clinicians, biologists, and mathematicians. It is funded by multiple NIH grants, foundation awards, and corporate contracts, occupying laboratories at Texas Children’s Hospital (1102 Bates, Suite 850, Houston, TX 77030).

Vikas Chopraمشاهده پروفایل

استاد

• Glaucoma
• Minimally Invasive Glaucoma Surgery
• Ocular Imaging
• +۳ مورد دیگر

Dr. Vikas Chopra holds the Charles Stewart Warren and Hildegard Warren Endowed Research Chair at Doheny Eye Centers-UCLA and serves as a Professor in the Department of Ophthalmology at the David Geffen School of Medicine, University of California, Los Angeles. He is a recognized expert in glaucoma surgical techniques, particularly Minimally Invasive Glaucoma Surgery (MIGS) procedures, and specializes in high-resolution ocular imaging for early and precise glaucoma evaluation. His research interests focus on developing new laser and surgical therapies for glaucoma and improving outcomes of complex combined cataract/glaucoma procedures. Analysis of his recent publications reveals consistent contributions to glaucoma diagnostics, surgical innovation, and treatment protocols, with particular emphasis on optical coherence tomography applications, MIGS outcomes, and combined surgical approaches. His work frequently appears in leading ophthalmology journals including Ophthalmology and Current Opinion in Ophthalmology. Super Doctors, Southern California (2022-2025) Top Doctors, Los Angeles Magazine (2021, 2024) Dr. Chopra is actively involved in surgical training of new ophthalmologists and serves on the committee that develops the American Board of Ophthalmology certification examinations. His clinical work spans multiple locations including the Doheny Eye Center UCLA Arcadia and Doheny Eye Center/UCLA Health - Pasadena, with hospital privileges at Ronald Reagan UCLA Medical Center. He is fluent in English, Spanish, and Hindi, enhancing his ability to serve diverse patient populations.